Company intelligence / Profile preview

ABM Respiratory Care

Singapore, Singapore

Ownership: Private
Employees: ~26
Development stage: Other

Overview

ABM Respiratory Care’s BiWaze Clear has received FDA 510(k) clearance, including expanded indications for use with ventilated patients in acute care environments; the company is actively commercializing devices for both hospital and home settings and increasing patient engagement and digital health capabilities.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Mercury Medical (US exclusive acute care distribution)

Beyond the preview

Go deeper on ABM Respiratory Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABM Respiratory Care.

Explore the full profile